|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$81,596,522 |
|
|
Indirect Value
|
$12,923,651,413 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,005,247,936 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 22 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VPHM |
Viropharma Inc |
10% Owner |
|
2008-03-13 |
4 |
B |
$8.69 |
$13,830 |
I/I |
1,591 |
129,281 |
1.5 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-07-31 |
4 |
B |
$9.00 |
$13,851 |
I/I |
1,539 |
283,583 |
2.17 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-14 |
4 |
B |
$7.41 |
$13,873 |
I/I |
1,871 |
96,941 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-06-20 |
4 |
B |
$7.30 |
$13,914 |
I/I |
1,906 |
698,811 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-23 |
4 |
B |
$25.71 |
$13,923 |
I/I |
539 |
188,912 |
2.17 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-06-20 |
4 |
S |
$7.38 |
$14,060 |
I/I |
(1,906) |
696,905 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-24 |
4 |
S |
$15.02 |
$14,195 |
I/I |
(945) |
14,223 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-08 |
4 |
B |
$10.00 |
$14,299 |
I/I |
1,318 |
281,615 |
2.17 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-09 |
4 |
S |
$13.00 |
$14,392 |
I/I |
(1,107) |
466,981 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-08-10 |
4 |
B |
$4.03 |
$14,503 |
I/I |
3,597 |
4,005,919 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-09 |
4 |
B |
$26.66 |
$14,520 |
I/I |
542 |
1,254,315 |
2.17 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-12-05 |
4 |
S |
$12.28 |
$14,544 |
I/I |
(1,184) |
98,756 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2009-05-18 |
4 |
B |
$5.84 |
$14,645 |
I/I |
2,455 |
184,253 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-03 |
4 |
B |
$5.71 |
$14,840 |
I/I |
2,598 |
4,608 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-27 |
4 |
B |
$14.17 |
$14,950 |
I/I |
1,037 |
130,973 |
2.17 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2005-07-14 |
4 |
B |
$3.50 |
$15,190 |
I/I |
4,340 |
53,540 |
1.5 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-07 |
4 |
B |
$6.37 |
$15,212 |
I/I |
2,223 |
203,310 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-12-05 |
4 |
B |
$28.39 |
$15,593 |
I/I |
548 |
192,064 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-08 |
4 |
B |
$30.36 |
$15,668 |
I/I |
516 |
227,840 |
2.17 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-03-17 |
4 |
B |
$8.14 |
$15,678 |
I/I |
1,927 |
2,204,248 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-26 |
4 |
B |
$14.24 |
$15,766 |
I/I |
1,107 |
129,936 |
2.17 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2009-05-11 |
4 |
B |
$5.86 |
$15,788 |
I/I |
2,695 |
169,519 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-22 |
4 |
B |
$16.67 |
$16,003 |
I/I |
960 |
193,104 |
2.17 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2006-11-17 |
4 |
B |
$5.75 |
$16,101 |
I/I |
2,802 |
144,265 |
1.5 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-29 |
4 |
S |
$4.12 |
$16,109 |
I/I |
(3,880) |
125,534 |
0 |
- |
|
1397 Records found
|
|
Page 22 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|